Eisai, Merck get FDA approval for LENVIMA capsules to treat HCC

Japan |  News | 0 Comment | 17 Aug, 2018

Eisai Inc. and Merck known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA® (lenvatinib) for ...Read more

Medtronic introduces IN.PACT Admiral DCB in Japan

Japan |  News | 0 Comment | 17 Aug, 2018

Dublin-based Medtronic has announced the commercial launch of the IN.PACT Admiral Drug-Coated Balloon (DCB) in Japan. IN.PACT Admiral DCB is a clinically proven, primary endovascular thera...Read more

Kaneka officially starts continuous manufacturing under GMP

Japan |  News | 0 Comment | 14 Aug, 2018

Japan based Kaneka Corporation has installed continuous manufacturing equipment to be applied to pharmaceutical products at Kaneka Singapore Co. (Pte.) Ltd with commercial production under ...Read more

Kyowa Hakko Kirin announces results of Phase 3 trial of patients with Cutaneous T-cell Lymphoma

Japan |  News | 0 Comment | 13 Aug, 2018

Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the use ...Read more

A device to assist exact hemodialysis catheter placement

Japan |  News | 0 Comment | 10 Aug, 2018

Researchers at Okayama University developed a supporting device for accurately placing hemodialysis catheters on kidney patients.    The device was successfully used on a group ...Read more

Takeda unite Ambys to treat serious liver disease

Japan |  News | 0 Comment | 10 Aug, 2018

Takeda has entered into a $100 million partnership with newly-launched biotech Ambys Medicines to support its discovery and development of therapies for people with serious liver disease. ...Read more

Qiagen, SRL to accelerate launch of companion diagnostics

Japan |  News | 0 Comment | 03 Aug, 2018

Qiagen N.V. has announced a collaboration with SRL, Inc., the largest clinical testing laboratory company in Japan, to prepare for introduction of new companion diagnostics simultaneous wit...Read more

Eisai to market anti-Obesity agent in China through CY Biotech

Japan |  News | 0 Comment | 31 Jul, 2018

Eisai Co., Ltd. announced that it has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, produc...Read more

Eisai, Merck gets U.S. FDA breakthrough therapy designation for LENVIMA

Japan |  News | 0 Comment | 31 Jul, 2018

Eisai Co., Ltd. and Merck & Co., Inc. announced  that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for LENVIMA (generic name: lenvatinib mes...Read more

Japan to lead human trial using stem cell to treat Parkinson's

Japan |  News | 0 Comment | 31 Jul, 2018

A team of researchers from Kyoto University, Japan has announced the world's first human trial using a kind of stem cell to treat Parkinson's disease, building on earlier animal trials. The...Read more

SanBio Receives $20 Million Grant From CIRM

Japan |  News | 0 Comment | 30 Jul, 2018

SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been awarded a $20 million grant from the California Institute of Regenerati...Read more

Mylan, Fujifilm Kyowa Kirin Biologics declares positive CHMP opinion for Hulio

Japan |  News | 0 Comment | 30 Jul, 2018

Mylan N.V. and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion f...Read more

Solasia Pharma announces approval of Sancusco in China

Japan |  News | 0 Comment | 27 Jul, 2018

Japan's Solasia Pharma, a specialty pharmaceutical company based in Asia, has officially announced that Sancuso (Granisetron Transdermal System) has been approved for launch by the China Na...Read more

Takeda Announces Phase III Trial of ALUNBRIG For Lung Cancer

Japan |  News | 0 Comment | 26 Jul, 2018

Takeda Pharmaceutical Company Limited has announced that the global, randomized, Phase 3 ALTA-1L (ALK in Lung Cancer Trial of AP26113 in 1stLine) trial met its primary e...Read more

Eisai, Biogen present Clinical study of Elenbecestat for Alzheimer's at AAIC 2018

Japan |  News | 0 Comment | 26 Jul, 2018

Eisai Co., Ltd. and Biogen Inc. announced detailed results from a Phase II clinical study (Study 202) of the investigational oral BACE (beta amyloid cleaving enzyme) inhibitor elenbecestat ...Read more

Terumo acquires China based Essen Tech

Japan |  News | 0 Comment | 26 Jul, 2018

Terumo Corporation recently announced that it has entered into an agreement to acquire Essen Technology (Beijing) Co., Ltd., a Chinese medical device company. Under the terms of the agreeme...Read more

Oramed gets Japanese Patent for GLP-1 analog capsule

Japan |  News | 0 Comment | 24 Jul, 2018

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. A clinical-stage pharmaceutical company announced that th...Read more

Researchers use AI to diagnose stomach cancer

Japan |  News | 0 Comment | 24 Jul, 2018

Researchers at Riken and the National Cancer Centre in Japan have succeeded in using artificial intelligence (AI) to identify early-stage stomach cancer with high accuracy. According to th...Read more